Xeris Pharmaceuticals | XERS - فروش و مدیریت هزینه





فروش و مدیریت هزینه تغییر دادن تاریخ
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Eli Lilly USD 3.13B 391.3M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09